Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre…

Overview of attention for article published in BMC Cancer, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

policy: 1 policy source
twitter: 4 X users

peer_reviews: 1 peer review site
facebook: 1 Facebook page

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 41 Mendeley

Summary Policy documents X Peer reviews Facebook Dimensions citations

So far, Altmetric has seen 1 peer review site that discusses this research output.

Publons

This paper has 1 review on Publons, an academic research evaluation site.

Review by Professor Dr. Sorush Niknamian

17 Jun 2019

This page shows the most recent peer reviews that mention this research output.

Click here to find out how to access more activity.